Your session is about to expire
← Back to Search
"Relax" descriptor for Cannabis Use
N/A
Waitlist Available
Led By Beth Reboussin, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Aged 18-65, inclusive
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after exposure to product packaging up to 1 minute
Awards & highlights
Study Summary
This trial looks at people's reactions to cannabis edibles, and how product descriptions affect their opinion.
Who is the study for?
This trial is for individuals who are interested in or have experience with cannabis use. Specific eligibility criteria to participate are not provided, so it's unclear who exactly can join.Check my eligibility
What is being tested?
The study aims to understand how different descriptions on cannabis edibles packaging influence people's opinions about the product, including its appeal and perceived harm, as well as their willingness to try these products.See study design
What are the potential side effects?
Since this trial focuses on perceptions rather than physical effects of consumption, side effects related to the interventions (product descriptors) are not applicable.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 65 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after exposure to product packaging up to 1 minute
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after exposure to product packaging up to 1 minute
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Harm Perceptions (Absolute)
Product Appeal Responses
Willingness to Try Product
Secondary outcome measures
Appeal to Children Responses
Harm Perceptions (Relative)
Other outcome measures
Perception of Quality Responses
Trial Design
10Treatment groups
Experimental Treatment
Group I: No descriptor (control)Experimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) without any product descriptors
Group II: "Vegan" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Vegan"
Group III: "Relax" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Relax"
Group IV: "Made with live resin" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Made with live resin"
Group V: "Handcrafted" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Handcrafted"
Group VI: "Gluten-free" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Gluten-free"
Group VII: "Fast-acting" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Fast-acting"
Group VIII: "Energy Boost" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "Energy Boost"
Group IX: "All Natural" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "All Natural."
Group X: "100% Organic" descriptorExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with the product descriptor "100% Organic"
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
"All Natural" descriptor
2024
N/A
~2740
"Energy Boost" descriptor
2024
N/A
~2740
"Relax" descriptor
2024
N/A
~2740
"Made with live resin" descriptor
2024
N/A
~2740
"Vegan" descriptor
2024
N/A
~2740
"Handcrafted" descriptor
2024
N/A
~2740
No descriptor (control)
2024
N/A
~2740
"Gluten-free" descriptor
2024
N/A
~2740
"100% Organic" descriptor
2024
N/A
~2740
"Fast-acting" descriptor
2024
N/A
~2740
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,243 Previous Clinical Trials
1,001,998 Total Patients Enrolled
1 Trials studying Cannabis Use
1,250 Patients Enrolled for Cannabis Use
National Institute on Drug Abuse (NIDA)NIH
2,470 Previous Clinical Trials
2,616,908 Total Patients Enrolled
28 Trials studying Cannabis Use
3,657 Patients Enrolled for Cannabis Use
Beth Reboussin, PhDPrincipal InvestigatorWake Forest University Health Sciences
1 Previous Clinical Trials
1,250 Total Patients Enrolled
1 Trials studying Cannabis Use
1,250 Patients Enrolled for Cannabis Use
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
To whom is eligibility to join this trial offered?
"To be eligible for this medical trial, interested parties must have a history of cannabis use and fall between 18 to 65 years old. The total number of participants required is 2500 individuals."
Answered by AI
Are there any opportunities to partake in this experiment presently?
"Data hosted on clinicaltrials.gov shows that, as of now, this medical trial is not actively recruiting patients. Initially posted at the start of 2024 and most recently updated in December 2023, it appears to be inactive for the moment; however there are 103 other studies currently looking for participants."
Answered by AI
Are participants below the age of 65 permissible in this experiment?
"This clinical trial is open to adults aged 18-65 years old. There are alternate trials available for those younger/older than the specified age range - 17 and 44 respectively."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger